J Gynecol Oncol.
2025 Mar;36(2):e89. 10.3802/jgo.2025.36.e89.
Author's reply to: Cisplatin versus carboplatin?
- Affiliations
-
- 1Department of Obstetrics and Gynecology, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon, Korea
- 2Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- KMID: 2576711
- DOI: http://doi.org/10.3802/jgo.2025.36.e89
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Comparative Study of the Toxicity Between carboplatin and Cisplatin in VBP Combination Chemotherapy
- Cisplatin versus carboplatin?
- Comparison of carboplatin-based chemotherapy versus cisplatin-based chemotherapy in the treatment of malignant gonadal germ cell tumor: a systematic review and meta-analysis
- TRAIL-induced cell death and caspase-8 activation are inhibited by cisplatin but not carboplatin
- Long-Term Survival Analysis of Intraperitoneal versus Intravenous Chemotherapy for Primary Ovarian Cancer and Comparison between Carboplatin- and Cisplatin-based Intraperitoneal Chemotherapy
